Corrections:
Correction: Incidence and risk of hematologic toxicities in cancer patients treated with regorafenib
Metrics: PDF 1422 views | ?
1 Center for Scientific Research, The Second Affiliated Hospital & Yuying Children’s Hospital, Wenzhou Medical University, Wenzhou, 325027, China
2 Department of Medical Oncology, The Third Affiliated Hospital of Harbin Medical University, Harbin, 150081, China
Published: January 04, 2019
This article has been corrected: The correct author affiliation information is given below:
Hong Zhao1,2
Original article: Oncotarget. 2017; 8:93813-93824. DOI: https://doi.org/10.18632/oncotarget.21217.
![Creative Commons License](/images/80x15.png)
PII: 26577